Skip to main content
. 2014 Sep 8;15(5):47–56. doi: 10.1120/jacmp.v15i5.4810

Figure 3.

Figure 3

DVHs of the nominal and 4D doses in a lung cancer patient: (a) DVHs for the GTV and CTV for the SFO plan; (b) DVHs for the GTV and CTV for the MFO plan; (c) DVHs for the PTV and OARs (lung, spinal cord, heart, and esophagus) for the SFO plan; (d) DVHs for the PTV and OARs for the MFO plan.